PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, providing promising enhancements across various healthcare and industrial apps. With its structural similarity to By natural means derived human serum albumin, OsrHSA provides a safer, much more trusted different for therapeutic use